P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
Abroad (travel likely)RecruitingPHASE1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · High-grade B-cell Lymphoma · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Transformed Follicular Lymphoma (tFL) · Follicular Lymphoma Grade 3B · DLBCL · DLBCL - Diffuse Large B Cell Lymphoma · DLBCL Arising From Follicular Lymphoma · DLBCL, Diffused Large B Cell Lymphoma · DLBCL NOS
Locations
- University of California San Diego, La Jolla, California, United States
- Loma Linda University Cancer Center, Loma Linda, California, United States
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- Advent Health Orlando, Orlando, Florida, United States
- Indiana University, Indianapolis, Indiana, United States
- Our Lady of the Lake Hospital, Baton Rouge, Louisiana, United States
- Ochsner Clinic Foundation, New Orleans, Louisiana, United States
- Wayne State - Karmanos Cancer Institute, Detroit, Michigan, United States
- NYU Grossman School of Medicine, New York, New York, United States
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
- University of Cincinnati, Cincinnati, Ohio, United States
- University of Oklahoma, Health Sciences Center, Oklahoma City, Oklahoma, United States
- Oregon Health & Science University, Portland, Oregon, United States
- Pennsylvania State University, Hershey, Pennsylvania, United States
- Prisma Health - Upstate Cancer Institute, Greenville, South Carolina, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
- Baylor Scott & White Research Institute, Dallas, Texas, United States